ER+HER2- Breast Cancer
3 clinical trials · Condition
◉ Watch ER+HER2- Breast Cancer
| Record | Firm | Date |
|---|---|---|
| SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer (NCT07109284) | West China Hospital | 2025-09-01 |
| Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer (NCT06964906) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-03-04 |
| A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. (NCT06064812) | Forward Pharmaceuticals Co., Ltd. | 2023-09-12 |
Track ER+HER2- Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.